Nicotine Dependence Clinical Trial
Official title:
Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Adolescent Smokers
Background:
- Multiple social, psychological, and environmental factors contribute to adolescents' use
of cigarettes. Environmental smoking cues have been shown to play an important role in
the maintenance of nicotine addiction and in relapse to smoking. However, few studies
have examined craving and cue-reactivity in adolescent smokers, even though craving
appears to contribute to ongoing smoking and relapse in this age group.
- Another factor central to addiction is the rewarding effect of drugs, or the interaction
between the person, the drug, and the environmental setting. However, more research is
needed on whether environmental cues lead to increased smoking in adolescents.
Objectives:
- To determine the effects of smoking versus neutral cues in adolescents who smoke on (1)
craving, mood, and autonomic responsivity and (2) the relative reinforcing efficacy of
tobacco cigarettes.
Eligibility:
- Adolescents 12 to 17 years of age who are current smokers (at least five cigarettes per day
for the past 6 months).
Design:
- This study will involve three study visits. Participants will be allowed to smoke before
all study sessions and will give a breath carbon monoxide (CO) sample before all
sessions. Participants must not use any illicit drugs or alcohol 24 hours before
sessions.
- Visit 1 (baseline session): Participants will provide a urine sample and will be
familiarized with the study room and session design.
- Visits 2 and 3: Participants will be connected to physiological recording devices to
measure heart rate, perspiration, and other physical responses. After baseline readings,
participants will be exposed to smoking cues at one experimental session and to neutral
cues at the other experimental session.
- Before, during, and after cue presentation, participants will complete self-report
measures of mood and craving and have physiological measures taken. They will then be
re-exposed to smoking or neutral cues and engage in a self-administration procedure to
examine the effect of cues on the reinforcing efficacy of cigarettes.
Objective:
To determine the effects of smoking versus neutral cues in adolescents who smoke on 1)
craving, mood, and autonomic responsivity and 2) the relative reinforcing efficacy of tobacco
cigarettes.
Study population:
25 adolescents who smoke at least 5 cigarettes per day.
Design:
Comparison-controlled, within-subjects design.
Outcome Measures:
During cue trials, primary measures include craving (TCQ-SF, VAS), mood (mood form, VAS), and
autonomic (heart rate, blood pressure, skin conductance) responsivity. During
self-administration trials, primary measures include breakpoint (final ratio completed),
total number of responses, and number of cigarette puffs earned and taken. Secondary measures
include baseline smoking history, mood, tobacco craving, smoking expectancies, nicotine
dependence, and urinary cotinine and 3-hydroxycotinine.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05176418 -
IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate
|
Early Phase 1 | |
Completed |
NCT04084210 -
Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use
|
Phase 2 | |
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Withdrawn |
NCT03707600 -
State and Trait Mediated Response to TMS in Substance Use Disorder
|
N/A | |
Recruiting |
NCT03999099 -
Targeting Orexin to Treat Nicotine Dependence
|
Phase 1 | |
Completed |
NCT03847155 -
Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery
|
N/A | |
Completed |
NCT02840435 -
Study on Sit to Quit Phone Intervention
|
N/A | |
Completed |
NCT02139930 -
Project 2: Strategies for Reducing Nicotine Content in Cigarettes
|
N/A | |
Completed |
NCT01926626 -
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
|
Phase 2 | |
Completed |
NCT01982110 -
A Mindfulness Based Application for Smoking Cessation
|
N/A | |
Completed |
NCT01632189 -
The Effect of Varenicline on D2/D3 Receptor Binding in Smokers
|
N/A | |
Withdrawn |
NCT01569477 -
Striving to Quit-Wisconsin Tobacco Quit Line
|
N/A | |
Completed |
NCT01685996 -
Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation
|
Phase 1/Phase 2 | |
Completed |
NCT01569490 -
Striving to Quit: First Breath
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT00996034 -
Nicotine Vaccination and Nicotinic Receptor Occupancy
|
Phase 2 | |
Completed |
NCT01061528 -
Coping Skills Treatment for Smoking Cessation
|
N/A | |
Suspended |
NCT01636336 -
Effects of Progesterone on Smoked Nicotine Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effects
|
N/A | |
Completed |
NCT01943994 -
Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
|
N/A | |
Withdrawn |
NCT01589081 -
Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect
|
N/A |